LYT-100 in Post-acute COVID-19 Respiratory Disease
Purpose of Study:
To evaluate the safety and efficacy of LYT-100 with post-acute COVID-19 respiratory complications who were treated with, but no longer require mechanical ventilation, extracorporeal membrane oxygenation, non-invasive ventilation (eg CPAP or BiPAP), high-flow nasal oxygen therapy, or combination thereof.
December 11, 2020 - December 30, 2021
Type of Study: